Previous Investigations
Other Litigations heparin FDA Health Advisory
|
US Regulators Monitor Contaminated Heparin and Adverse Reactions in Patients
Those who have been harmed may complete the form below for a free legal review
The Food and Drug Aministration (FDA) is actively involved in the investigation of those who have experienced adverse reactions related to contaminated Heparin products.
They have provided informational charts on several regulatory issues, including how they monitor and analyze adverse patient reactions to contaminated Heparin.
Adverse Reaction:
Some patients experience severe allergic reaction and/or low blood
pressure after receiving heparin.
Reporting:
A small percentage of adverse reactions are
reported to the Centers for Disease Control and Prevention and to the FDA by
health care professionals and industry.
In-Depth Analysis:
The FDA analyzes data, defines
patterns and contacts health care professionals to collect more data and
information on cases that fit the pattern.
Zeroing In:
The FDA uses the data to better define a
pattern on related adverse reactions from among the number of
reported cases.
For additional information from the FDA, click here.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
Baxter Heparin Label Errors
Important Safety Alert: Baxter Heparin Sodium Injection and Hep-Lock Baxter Heparin products with blue labeling were accidentally swapped
Heparin Warning Letter
FDA Warning Letter Sent to Heparin Plant Changzhou SPL CompanyWarning letter cites dangerous practices that led to heparin injuries
FDA Health Advisory
FDA Issues Advisory on Heparin Due to Health Risks--Free Lawsuit InfoDid You Suffer Adverse Reaction After Heparin Injection? Lawsuit info
